CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

Bringing a drug to market: How do we find and monitor suitable patients?

What will happen when we eventually develop a treatment that halts the development of early Alzheimer’s disease? Being first-in-class, pharmacovigilance post-marketing will be vitally important to ascertain the long-term effects of the drug: both positive and negative. We need to be prepared for a breakthrough and pre-emptively identify technologies which can find the right patients likely to benefit from the drug and monitor treatment effects in the real world. 

Wearable devices: the future for near-patient testing?

Cognition Kit and Takeda have collaborated to deliver high frequency assessments of mood and cognition in major depressive disorder, using the Apple Watch. 

Takeda and Cognition Kit partner to pilot wearables in patients with Major Depressive Disorder (MDD)

Takeda Pharmaceuticals U.S.A. and Cognition Kit Limited announce a collaboration to pilot the use of a specially designed app on an Apple Watch wearable to monitor and assess cognitive function in patients with Major Depressive Disorder (MDD).

web-based testing, wearables, voice recognition, virtual research, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, soc, smartphones, schizophrenia research, schizophrenia, research funding, remote testing, regulations, recruitment, real-world assessments, prodromal, pro-cognitive, presenteeism, preclinical, precision psychiatry, pre-clinical, physical health, personalised medicine, patient-centric, patient recruitment, patient finding, parkinson's disease, pal, ots, opinion piece, occupational health, objective measures, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, modafinil, mental wellbeing, mental health, mci, major depression, lifespan, innovate uk, ied, icosr, high frequency, healthcare, ert, epidemiology, emotion recognition, ecological momentary assessments, ebt, ebbinghaus, early alzheimer's disease, drug development, digital tools, digital health, diagnosis, depression, dementia, computerised testing, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic pain, cgt, cantab research grant, cantab for clinical trials, cantab, brain health, brain donor program, biomarkers, awards, automatic speech recognition, autism, attention, at-home testing, asd, alzheimer's disease, affective cognition, absenteeism,